NOT YET RECRUITING
NCT07931937
FIA Acute Inflammation
The goal of this clinical trial is to learn how acute inflammation affects the body's ability to absorb iron in adults who are hospitalized with community-acquired pneumonia.
The main questions it aims to answer are:
* How does intestinal iron absorption change during acute inflammation compared with after recovery?
* How are changes in iron absorption related to markers of iron metabolism and inflammation, including hepcidin?
Participants will:
* Receive an oral dose of stable isotope-labelled ⁵⁷Fe-ferrous sulfate, followed one hour later by a small intravenous dose of stable isotope-labelled ⁵⁸Fe-citrate.
* Provide blood samples to measure iron absorption, iron status, and markers of inflammation.
* Repeat the study procedures after recovery from the acute illness to compare iron absorption during acute inflammation and convalescence.
* Attend follow-up visits over approximately 3-4 months.
Gender: All
Ages: 18 Years - Any
Inflammation
Iron Absorption
Community-Acquired Pneumonia (CAP)
+2